The European Commission has established maximum limits of AFB1 in feed, ranging from 5 to 20 g/kg
Although it came after our FY22 timeframe, the letter is worth mentioning because, in this case, the agency held the firm responsible for potentially causing downstream cGMP violations due to their inadequate testing methods
Conversely, participants receiving GLP-1 RAs were consistently more likely to report experiencing gastrointestinal side effects
Abnormal results might mean a dose change, more frequent testing, additional tests, or stopping the drug
The medication works identically to brand-name semaglutide because the chemical compound is the samethe only difference is the manufacturer and distribution pathway
In addition, software-related technologies and any other applicable advanced technologies should be analyzed and utilized